Ideaya Biosciences (IDYA) Mentioned Positively at Citi, 'developing into an attractive takeout candidate'

December 5, 2023 6:07 AM EST Send to a Friend
Citi analyst Yigal Nochomovitz reiterated a Buy rating and $40.00 price target on Ideaya Biosciences (NASDAQ: IDYA)The analyst comments "IDYA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login